Skip to main content

Accomplished Patent Attorney, Dr. Melissa Hunter-Ensor, Joins Greenberg Traurig’s Intellectual Property Group in Boston

Dr. Hunter-Ensor is Joined by Elbert C. Chiang, Ph.D.; Together they Bolster IP Group’s Strong Life Sciences Industry Experience

BOSTON — June 29, 2016 — Global law firm Greenberg Traurig, LLP has added Dr. Melissa Hunter-Ensor as a shareholder in the firm’s Intellectual Property (IP) Group in the Boston office. She is joined by registered patent agent, Elbert C. Chiang, Ph.D. Both Dr. Hunter-Ensor and Dr. Chiang were previously at Saul Ewing LLP in Boston.

Dr. Hunter-Ensor is a registered patent attorney who focuses her practice on the intellectual property (IP) and commercial needs of clients in the life science industry, including pharmaceutical, biotechnology, chemical, agricultural, diagnostics, and medical device companies. She has experience representing clients throughout the business cycle, from start-ups and universities to global pharmaceutical companies, with patent portfolio management and strategic alliances, as well as litigation and pre-litigation strategy. She also assists venture capital firms and other investors in assessing the IP risks of target investments and conducts IP patent and licensing due diligence in connection with life science technology transactions.

Before becoming a lawyer, Dr. Hunter-Ensor earned a Ph.D. in neuroscience from the University of Pennsylvania and her thesis research resulted in a first author paper in Cell. She followed this accomplishment with a four-year post-doctoral fellowship at the Massachusetts Institute of Technology laboratory of Nobel laureate H. Robert Horvitz where she was a Jane Coffin Childs fellow.

Dr. Chiang is a registered patent agent who focuses on patent preparation and prosecution, particularly for the biotechnology and pharmaceutical industries in the United States and abroad. He also has experience drafting and assisting on legal opinions related to patentability, freedom to operate, invalidity, and infringement. He has a Ph.D. from Princeton University and a bachelor’s degree from Vanderbilt University, both in molecular biology.

Terence P. McCourt, managing shareholder of Greenberg Traurig’s Boston office, said, “Dr. Hunter-Ensor is a well-known and accomplished IP lawyer, and we are delighted that she is joining our firm. We look forward to the depth and sophistication of skill and experience that she will bring to our Boston office and the Greenberg Traurig practice worldwide. We welcome her and Dr. Chiang to the team.”

“Greenberg Traurig is a great fit for my practice,” said Dr. Hunter-Ensor. “The global firm is well-known for its collaborative culture and entrepreneurial approach, and the IP Group is recognized for its work in life sciences and medical technologies. I look forward to being part of this growing team.”

“Dr. Hunter-Ensor brings high level expertise to Greenberg Traurig’s Global Life Sciences & Medical Technology Group and the Boston office,” said David J. Dykeman, co-chair of Greenberg Traurig’s global Life Sciences & Medical Technology Group, and co-chair of the firm’s Intellectual Property Group in Boston. “Dr. Hunter-Ensor and Dr. Chiang bolster Greenberg Traurig’s IP practice in the pharmaceuticals and biotechnology which are important sectors in today’s innovation economy.”

About Greenberg Traurig, LLP

Greenberg Traurig, LLP (GTLaw) has more than 2,000 attorneys in 38 offices in the United States, Latin America, Europe, Asia and the Middle East and is celebrating its 50th anniversary. One firm worldwide, GTLaw has been recognized for its philanthropic giving, was named the largest firm in the U.S. by Law360 in 2017, and among the Top 20 on the 2016 Am Law Global 100. Web: Twitter: @GT_Law.